Compare

Novartis vs Beone Medicines

Novartis (NVS) and Beone Medicines (ONC) side by side, from official filings: what insiders, members of Congress and funds reported. These are counts of what was filed, not a view on either stock.

Novartis NVSNYSE · Pharmaceutical PreparationsBeone Medicines ONCNASDAQ · Pharmaceutical Preparations
Insider records, last 12 months013
Congress trades, last 12 months00
Fund positions reported, last 12 months5029
Federal contract awards, last 12 months00
Open-market purchases by insiders since 2006015
Open-market sales by insiders since 200601,483
Last open-market purchase by an insiderNone on recordSep 10, 2021
Next resultsNot announcedNot announced

Counts of records OQRO holds, by their date. Insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned and automatic sales are included in the sales.

Common questions

Which has had more insider buying, Novartis or Beone Medicines?

Since 2006, Beone Medicines insiders reported 15 open-market purchases against 0 for Novartis, in SEC Forms 4 and 5. Counts depend on the number of insiders and how long each company has been listed.

Do members of Congress trade NVS or ONC?

In the last 12 months, members of Congress disclosed 0 trades in Novartis (NVS) and 0 in Beone Medicines (ONC), each reported as a value range on a periodic transaction report.

When did insiders last buy NVS and ONC?

Novartis: no open-market purchase on record. Beone Medicines: Sep 10, 2021. Dates are those of the SEC filings.

See the record behind any of these

Each company page opens free with one real filing and the counts of the last 12 months. OQRO Pro adds the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.

Get OQRO ProOpen Novartis free$9.99 a month, cancel anytime

Novartis pageBeone Medicines pageRare insider trades this weekAll comparisons

https://oqro.io/compare/nvs-vs-onc